Form 8-K · Current report
Clorox 8-K, filed Oct 29, 2026
- Filed
- CIK
- 0000021076
- Accession no.
- 0001206774-26-000586
Summary
Clorox's board appointed Fabian Garcia, currently president of Unilever Personal Care, as chief executive effective January 5, 2027, succeeding Linda Rendle, who announced in May she would step down for health reasons and will stay on as a senior advisor through April 2, 2027. Matthew Shattock, the lead independent director, will become independent chair at that date, and Shattock said the board is confident Garcia can build on Rendle's foundation and strengthen execution.
Key points
- Garcia has led Unilever's personal care business since 2022, was previously CEO of Revlon and a chief operating officer at Colgate-Palmolive, and serves on Wells Fargo's board.
- Garcia's offer letter provides a $2,000,000 target annual bonus, a $4,550,000 initial long-term incentive award and an $11,000,000 sign-on restricted stock unit award tied to equity forfeited at his prior employer.
- Rendle's transition is treated as a "Retirement" under her outstanding long-term incentive awards, which vest on their original terms, and she receives no new equity during the advisory period.
- Clorox said it will report first-quarter fiscal 2027 results on November 2, with Rendle and chief financial officer Luc Bellet participating in the analyst call.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 28, 2026, the Board of Directors (the “Board”) of The Clorox Company (the “Company”), appointed Fabian Garcia to serve as the Chief Executive Officer (“CEO”) of the Company and a member of the Board, effective as of January 5, 2027 (the “Effective Date”). Linda Rendle will step down from her role as CEO of the Company and Chair and a member of the Board as of the Effective Date and will serve as a senior advisor to the Company through April 2, 2027, to assist with transition matters. As of the Effective Date, Matthew J. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.